News
Just as it's doing with nearly every facet of society around the world, the COVID-19 crisis will radically transform approaches with patient engagement and pop health. From telemedicine and remote patient monitoring to AI and advanced analytics, healthcare was already in the midst of big changes in how it manages the health of patient populations. Now, in a new era where the pandemic is upending old assumptions, the stakes are even higher. This month, we look at how approaches to treating COVID-19 and other illnesses are shifting in this new era.
A new guidance from the U.S. regulator relaxes a handful of requirements for these digital health devices, and clarifies the agency's long-term enforcement policy for low-risk wellness products.
The health system is implementing new technologies to help it pinpoint frequent readmissions and identify underlying social determinants of health.
COVID-19
An integrated virtual clinic app has been designed to take the heat out of the struggle to maintain appointment levels when they are under intense stress from the COVID-19 response, as the situation steps up the pace of digital transformation.
JN Medsys has obtained approval for their PCR Kit from the FDA of the Philippines, and is in the process of obtaining approval from the US FDA.
The remote monitoring health tech company’s timely name-change coincides with a radical shift in the way health data is perceived and used, triggered by the coronavirus pandemic.
They signed deals with MaQuestionMedicale in France and HomeDoctor in Spain.
The world’s smallest smart thermometer offers a cloud-based continuous remote system for temperature monitoring and allows users to receive alerts when abnormal body temperature is detected.
Many are anticipating greater adoption of digital health services and more favorable regulatory and reimbursement environments, according to a recent poll sampling 513 digital health and adjacent companies.
The new effort is a measure of progress towards a digital health ecosystem.